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Summary
Background Renal failure represents a growing but mostly undocumented cause of premature mortality in low-income 
and middle-income countries. We investigated changes in adult renal failure mortality and its key risk factors in India 
using the nationally representative Million Death Study.
Methods In this cross-sectional analysis of population-based data, two trained physicians independently assigned 
underlying causes to 150 018 deaths at ages 15–69 years from a nationally-representative mortality survey in India for 
2001–03 and 2010–13, using the International Classiﬁ cation of Diseases, 10th version (ICD-10). We applied the age-
speciﬁ c proportion of renal failure deaths for the 2010–13 period to the 2015 UN estimates of total deaths in India and 
calculated age-standardised death rates for renal failure by rural or urban residence, state, and age group. We used 
proportional mortality of renal deaths (cases) to injuries (controls) to calculate the odds of renal death in the presence of 
diﬀ erent comorbidities and stratiﬁ ed risks by decade of birth.
Findings In 2001–03, 2·1% of total deaths among 15–69 year olds were from renal failure (1266 [2·2%] of 58 871; 
unweighted). By 2010–13, the proportion of deaths from renal failure had risen to 2·9% (2943 [3·2%] of 91 147; 
unweighted) of total deaths and corresponding to 136 000 renal failure deaths (range 108 000–150 000) of 4 688 000 
total deaths nationally in 2015. Age-standardised renal death rates were highest in the southern and eastern states, 
particularly among adults aged 45–69 years in 2010–13. Diabetes, hypertension, and cardiovascular disease were all 
signiﬁ cantly associated with increased renal failure deaths, with diabetes the strongest predictor—odds ratio (OR) vs 
control 9·2 (95% CI 6·7–12·7) in 2001–03, rising to 15·1 (12·6–18·1) in 2010–13. In the 2010–13 study population, the 
diabetes to non-diabetes OR was twice as large in adults born in the 1970s (25·5, 95% CI 17·6–37·1) as in those 
individuals born during or before the 1950s (11·7, 9·1–14·9). 
Interpretation Renal failure is a growing cause of premature death in India. Poorly treated diabetes is the most 
probable reason for this increase. Strategies aimed at diabetes prevention, and early detection and treatment are 
urgently needed in India, as well as greater access to renal replacement therapy.
Funding US National Institutes of Health, International Development Research Centre, Centre for Global Health 
Research, University of Toronto.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license. 
Introduction
In many high-income countries the prevalence of chronic 
kidney disease approaches 15% of the adult population,1 
predominantly due to diabetic and hypertensive 
nephropathy, and poses a large medical and economic 
burden.2 Kidney disease and death from renal failure is 
also a major, but poorly documented burden for low-
income and middle-income countries. In low-income 
countries, infectious causes, environmental pollutants, 
and toxins are thought to be the primary causes of both 
acute kidney injury and chronic kidney disease.3 Middle-
income countries, such as India, which are undergoing 
rapid economic and epidemiological transitions appear 
to be facing a double burden, with continued high 
prevalence of infectious causes of kidney disease as well 
as rising rates of hypertension and particularly of 
untreated diabetes.3–5
In India, nationally representative, population-based 
data for renal failure incidence, prevalence, and deaths are 
absent at both a national and a subnational level. However, 
several factors suggest morbidity and mortality from renal 
failure is likely to be a growing public health concern for 
India. The prevalence of diabetes is estimated at 9% 
among adults in urban India, and is greater among those 
who are overweight or wealthy.6 Hypertension prevalence 
is also rising in both urban and rural India.7 Because the 
development of chronic kidney disease is insidious, and 
aetiologies such as diabetes and hypertension are often 
underdiagnosed at the popu lation level, presentation with 
kidney disease is typically late;8 for example, in one study,9 
end-stage renal failure accounted for about half of all 
chronic kidney disease presentations in India.
In this Article, we aimed to estimate renal failure 
mortality in the nationally representative Million Death 
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Study (MDS) conducted in India, comparing data for 
2001–03 and 2010–13. We estimate the number of 
adults deaths from renal failure, the contribution of 
diabetes, hypertension and cardiovascular disease, and 
changes over time in each period.
Methods
Study design
Details of the MDS, including study design, physician 
assignment of the underlying cause of death, and 
statistical methods have been published elsewhere.10–12 
Brieﬂ y, the study uses an enhanced type of verbal autopsy 
method (a structured survey administered to a household 
member or close relative of the deceased by a trained 
non-medical ﬁ eld worker to record the signs and 
symptoms that occurred before death—this information 
is used to assign the most probable cause of death13). 
From 2001 onwards, the MDS has monitored annual 
deaths in 1·3 million representative households within 
the Registrar General of India (RGI)’s Sample 
Registration System (SRS). The SRS partitions India into 
1 million small areas after each census, from which 
6671 small areas from the 2001 census and 7597 small 
areas from the 2011 census are randomly selected for 
continuous monitoring of household births and 
deaths. One of 800 non-medical RGI surveyors visits 
each house every 6 months and for any household with a 
death, interviews a family member or associate of the 
deceased and completes a two-page form14 with structured 
questions and a half-page local language narrative that 
probes the presence or absence of key symptoms before 
death. For all deaths in people over 15 years of age, the 
surveyors ask the living respondent about the deceased’s 
use of smoked or chewed tobacco and alcohol, and 
whether a doctor had ever diagnosed heart disease, 
stroke, hypertension, or diabetes. The ﬁ eld records are 
converted to electronic records and emailed 
independently to two of 400 specially trained physicians 
able to read the local language. Physician coding follows 
guidelines for the major underlying causes of deaths, 
coded using the International Classiﬁ cation of Diseases 
and Related Health Problems, 10th version (ICD-10).15 
ICD-10 coding diﬀ erences undergo anonymous 
reconciliation by each of the two physicians, and 
persisting diﬀ erences are adjudicated by a third 
physician. Random independent resampling of about 3% 
of deaths has shown cause-of-death results to be 
consistent with the RGI ﬁ eldwork.10,16
We focused on renal failure deaths (ICD-10 codes 
N00–N19) in adults aged 15–69 years because deaths at 
these ages are more likely to be avoidable and have lower 
unclassiﬁ able causes than deaths at older ages.10–12 
Biochemical or pathological conﬁ rmation of renal failure 
or kidney disease, while desirable, was not available in 
most cases.
Statistical analysis
We calculated age-speciﬁ c and age-standardised death 
rates (directly, using the WHO standard population17) 
using the 2008 SRS total death rates by state for the 
2001–03 study period and the 2013 SRS total death rates 
by state for the 2010–13 study period. We applied the 
sample-weighted MDS proportion from 2010–13 to the 
2015 United Nations18 estimates of total deaths in India 
to estimate total renal failure deaths, as described 
previously.19 We compared prevalence of diabetes, 
hypertension, cardiovascular disease, and tuberculosis, 
as well as smoking and drinking (among males, because 
Research in context
Evidence before this study
We systematically searched PubMed and Embase databases with 
no speciﬁ ed start date up to Aug 1, 2016 for English language 
sources. We used the following PubMed search terms and 
translated appropriately for Embase: (“kidney disease” [MeSH], 
OR “renal failure”[MeSH]) AND (“mortality estimates” [tw], OR 
“burden of disease” [tw], OR “disease burden” OR “household” 
[tw] AND “survey” [tw]). We further delineated by low-income 
or middle-income countries, and speciﬁ cally screened for 
representative, population-based studies of mortality due to 
renal failure. We found no nationally representative, 
population-based studies of renal failure mortality for any 
middle-income country. Population-based studies at the state 
and community level of renal failure incidence and prevalence 
exist for India, but any estimations of national mortality drawn 
from these are likely to be weak because these are typically not 
representatively sampled, and because as our study ﬁ ndings 
show, subnational age-standardised rates of renal failure 
mortality vary widely within India.
Added value of this study
To our knowledge, our study results provide the ﬁ rst 
nationally representative population-based estimate of deaths 
from renal failure in any low-income and middle-income 
country, and show that renal failure is a growing public health 
concern for India. We establish that much of the high burden 
and rising death rates are due to diabetes. Our estimates also 
show very low coverage of renal replacement therapy (dialysis 
and transplantation).
Implications of all the available evidence
Renal failure is an important and growing cause of premature 
adult mortality in India, driven by the rising prevalence of poorly 
treated diabetes, especially in urban areas. Access to dialysis and 
transplantation is poor and not commensurate with the large 
and rising burden of renal disease. Greater priority should be 
given to addressing renal failure as well as access to preventive 
and treatment services, including for diabetes, in India and other 
comparable middle-income countries. 
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few women smoke or drink alcohol in India),20 and rural 
versus urban residence among renal failure deaths 
(cases) with prevalence among deaths of a control group 
(people who died from injuries; ICD V00–Y99).12 
Proportional mortality assumes that the comorbid 
prevalence among the deceased in the control group is 
broadly similar to that observed in the general population, 
and that any biases in reporting are similar between case 
and control deaths.21 Because control deaths were 
generally younger than renal failure deaths, we 
standardised percentages for comorbidities to the age 
distribution of all cases in 2010–13. We used logistic 
regression to calculate odds ratios (OR) for deaths from 
renal failure versus control deaths in the presence of 
diﬀ erent comorbidities,22 adjusting for age (linear), night-
time light exposure as a proxy for socioeconomic 
status,23,24 urban residence, smoking, and alcohol use. We 
stratiﬁ ed risks by birth cohort, comparing adults born on 
or before 1955 (1950s birth cohort), 1956–65 (1960s), and 
1966–75 (1970s). We also did subgroup analysis by sex for 
the proportional mortality analysis. We excluded missing 
data (<5% for exposures and <1% for deaths or birth 
cohorts) from the logistic regression. The main source of 
uncertainty in the MDS estimates arises from assignment 
to the ICD-10 codes for renal failure deaths and not from 
random variation, given the large sample size of the 
MDS.10 Thus, we provide lower bounds for the national 
totals if the death had been immediately attributed to 
renal failure by both physicians (hence, no subsequent 
reconciliation or adjudication was needed). Upper 
bounds were the cases in which only one physician 
attributed the underlying cause to renal failure (these 
cases were assigned to other conditions during 
subsequent reconciliation or adjudication). Standard 
95% CIs are provided for the regression model for the 
proportional mortality analyses. Statistical analysis used 
Stata version 14 and ArcMap 10.3 and PostGIS 2.0.
As a supplementary analysis, using data from a national 
survey of dialysis units in India in 2009,25,26 we geocoded 
dialysis units using postal codes and computed spatial 
buﬀ ers at distance bands: 0–19·9 km, 20–49·9 km, and 
50–99·9 km around each unit. We used the buﬀ ers and a 
population grid27 to extract the number of people living 
within each buﬀ er. We calculated coverage per million 
population of renal transplantation as reported by the WHO 
Global Observatory on Organ Transplantation.28 Because 
India does not have a formal national transplant registry, 
renal transplantation rates represent best estimates only.
Role of the funding source
The funding sources had no role in the study design, 
conduct, data collection, analysis, or interpretation. PJ 
had full access to all data and ﬁ nal responsibility for the 
decision to submit for publication on behalf of all authors.
Results
In 2001–03, 2·1% of total deaths among 15–69 year olds 
were from renal failure (1266 [2·2%] of 58 871; unweighted). 
By 2010–13, the proportion of deaths from renal failure had 
risen to 2·9% (2943 [3·2%] of 91 147; unweighted) of total 
deaths (table 1). The age-standardised rate (all reported as 
per 100 000 population) for renal failure death at ages 
15–69 years was 13 in 2001–03 and 17 in 2010–13. Among 
45–69 year olds, the age-standardised death rate rose from 
30 in 2001–03 to 40 in 2010–13. By comparison, the national 
age-standardised death rate for renal failure in 15–44 year 
olds remained relatively static across the study periods at 
about 5. The age-standardised death rates at ages 
45–69 years were signiﬁ cantly higher overall in urban 
areas than in rural areas, and rose from 37 in 2001–03 to 45 
in 2010–13 in urban areas and 27 in 2001–03 to 37 in 
2010–13 in rural areas. The overall risk of death from renal 
failure at ages 15–69 years was 1·42%, in the hypothetical 
absence of other causes.
Study deaths, 2001–03 Study deaths, 2010–13 All India, 2015
Renal failure 
deaths/all 
coded deaths
Proportion renal 
failure (%)*
Urban 
deaths
Renal failure 
deaths/all 
coded deaths
Proportion renal 
failure (%)*
Urban 
deaths†
All deaths/population 
(thousands)†
Estimated deaths 
(thousands)*
Estimated deaths 
per 100 000*‡
Period risk 
(%)§
0–14 years 82/27 170 0·3% 9 72/25 885 0·2% 14 1444/377 427 3 2·3 0·03%
15–29 years 137/9041 1·5% 33 229/11 978 1·7% 73 535/354 355 9 7·2 0·11%
30–44 years 249/10 780 2·2% 55 524/16 587 2·7% 152 813/276 524 22 17·3 0·26%
45–59 years 449/18 028 2·5% 129 1146/29 435 3·6% 388 1544/186 192 56 43·9 0·66%
60–69 years 431/21 022 1·9% 109 1044/33 147 2·8% 317 1796/71 961 50 39·7 0·40%
>70 years 564/35 835 1·5% 146 1202/65 116 1·5% 385 3449/44 592 52 40·8 0·82%
Overall
15–69 years 1266/58 871 2·1% 326 2943/91 147 2·9% 930 4688/889 032 136 15·3 1·42%
Bounds¶ 838–1531 1·3–2·5 221–393 2304–3290 2·3–3·2 726–1020 ·· 108–150 12–17 ··
*Weighted for sampling probability. †For each age range sample-weighted percentages are multiplied by the UN estimated number of all deaths in 2015 to estimate national renal failure mortality. ‡Age-specific 
rates, per 100 000. §Annual rate multiplied by the duration of age range, except for the period risk for 15–69 years which was calculated by summation of the age-speciﬁ c period risks (giving the probability of 
death from renal failure at ages 15–69 years in the absence of other causes of death). ¶Lower and upper bound estimates are based on both physicians immediately agreeing that the underlying cause of death was 
renal failure or if only one physician chose this diagnosis.
Table 1: Renal failure deaths among Indians in the Million Death Study, and estimated national totals 2001–03 and 2010–13
Articles
e92 www.thelancet.com/lancetgh   Vol 5   January 2017
Results for subgroup analysis by sex are not presented 
because we identiﬁ ed no signiﬁ cant diﬀ erences in death 
patterns or risk factors between men and women. At ages 
15–69 years the proportion of renal failure deaths in the 
study (2·9%) corresponds to an estimated 136 000 renal 
failure deaths (range 108 000–150 000, based on the two 
physicians immediately agreeing if the death was from 
renal failure or not) of 4 688 000 total deaths in 2015 (UN 
death estimates,18 India 2015). The median age of renal 
failure death was 55 years (IQR 42–63) for patients aged 
15–69 years during the two study periods. Deaths from 
renal failure were more common in male individuals in 
2010–13 (64%, 1888 of 2943 total deaths) with similar 
proportions in 2001–03 (63·5%, 804 of 1266). Although 
the age-standardised rate of death was higher in urban 
areas than in rural areas, the total number of deaths was 
greatest in rural India, in keeping with population 
distribution. However, the percentage of total urban 
deaths rose from 26% (326 deaths) in 2001–03 to 32% 
(930 deaths) in 2010–13. With far less certainty than for 
ages 15–69 years, 52 000 renal failure deaths occurred 
nationally at ages 70 years or older.
Renal failure deaths varied substantially, 
geographically and temporally, at the state level within 
India. The age-standardised death rate from renal 
failure rose notably in the eastern and southern states, 
particularly among 45–69 year olds (ﬁ gure 1). The death 
rate from renal failure per 100 000 population at ages 
15–69 years was highest in the southern state of Tamil 
Nadu and increased over the study period (17 in 2001–03 
and 20 in 2010–13 for 0–69 years; 56 in 2001–03 and 
65 in 2010–13 among 45–69 year olds). Modest increases 
also occurred in the southern states of Kerala, Andhra 
Pradesh, and Karnataka. The eastern states of Assam, 
West Bengal, Orissa, and Jharkhand also had high death 
rates and experienced the greatest increase throughout 
the two time periods, mostly as a result of the rapidly 
rising death rates in the 45–69 year age group. By 
2010–13, these eastern states had renal failure death 
rates of more than 50 per 100 000 population, almost 
double that in 2001–03. Geographical disparity also 
increased during the study period because renal death 
rates in the northern and western states remained 
relatively static during the two study periods whereas 
rates in the southern and eastern states increased.
The prevalence of diabetes among renal failure deaths 
rose from 26% in 2001–03 to 34% in 2010–13 (table 2). By 
contrast, 16% of control deaths were patients known to 
be diabetic in 2001–03 and 23% were in 2010–13, after 
standardising to the age-distribution of renal failure 
deaths. The diabetes to non-diabetes OR was higher 
among renal failure deaths than among control deaths at 
both timepoints, after adjusting for hypertension, 
cardiovascular history, and smoking (table 2). In the 
Figure 1: Age-standardised renal failure death rates among Indian adults aged 45–69 years in (A) 2001–03 and (B) 2010–13
Age-standardised death rates for renal failure deaths were calculated directly, per 100 000 population, using the WHO standard population18 and the population of the 
2008 SRS death rates by state for 2001–03 and 2013 SRS death rates by state for 2010–13. AP=Andhra Pradesh. AS=Assam. BR=Bihar. CG=Chhattisgarh. DL=Delhi. 
GJ=Gujarat. HP=Himachal Pradesh. HR=Haryana. JH=Jharkhand. JK=Jammu and Kashmir. KA=Karnataka. KL=Kerala. MH=Maharashtra. MP=Madhya Pradesh. OR=Odisha. 
PB=Punjab. RJ=Rajasthan. TN=Tamil Nadu. UP=Uttar Pradesh. WB=West Bengal. SRS=sample registration system.
RJ
21
MP
24
MH
30
AP
35
JK
33
UP
17
GJ
34
KA
29
OR
29
TN
56
CG
15
BR
18
JH
21
WB
33
HP
36
PB
40
HR
32
AS
37
KL
36
DL
45
RJ
17
MP
32
MH
40
AP
47
JK
33
UP
29
GJ
34
KA
48
OR
54
TN
65
CG
36
BR
9
JH
51
WB
51
HP
39
PB
46
HR
34
AS
53
KL
48
DL
44
  
N
A 2001–03 B 2010–13
Age-standardised death
rates (per 100 000)
 46–65
 36–45
 30–35
 9–29
 No data
Articles
www.thelancet.com/lancetgh   Vol 5   January 2017 e93
2010–13 study population, the diabetes to non-diabetes 
OR was twice as large in adults born in the 1970s (25·5, 
95% CI 17·6–37·1) as in those born during or before the 
1950s (11·7, 9·1–14·9; ﬁ gure 2). The OR for hypertension 
and cardiovascular disease were less strongly associated 
with renal failure deaths, and smoking was modestly 
associated in 2010–13 (table 2). Because drinking alcohol 
is probably selectively under-reported among injury 
controls, the observed excess ORs in both time periods 
are probably artifacts (table 2).29
Discussion
Our nationally representative mortality surveys show that 
renal failure contributes substantially to adult premature 
death before 70 years of age in India, and represents a 
growing cause of death. In 2015, we estimate that about 
136 000 Indian adults died prematurely as a result of renal 
failure, representing about 3% of all premature adult 
mortality, 1·5 times the proportions observed a decade 
earlier. Renal failure deaths now exceed AIDS-related 
deaths in India.30,31 We also noted substantial geographical 
variation in renal failure mortality within India, with 
renal failure death rates highest in urban India and in the 
southern and eastern states. Diabetes was the most 
important risk factor associated with death from renal 
failure among adults at all ages; it was associated with the 
highest odds of renal failure death and by 2010–13 was 
also the most frequently occurring comorbid risk factor 
among renal failure cases. The risk associated with 
diabetes increased between study periods and was 
particularly high in cohorts of more recently born adults.
These ﬁ ndings highlight a rapidly changing pattern of 
mortality in India12 away from deaths from infectious 
diseases in rural areas, to chronic non-communicable 
Figure 2: Birth cohort analysis of comorbidities among Indian adults and risk 
of renal failure death, 2010–13
The y-axis is on a doubling scale. Numbers on the x-axis represent case (renal 
failure) and control (injuries; V00–Y99) deaths at each decade. Cases and 
controls with missing information were excluded from these totals. The 
1980s onwards cohort was excluded on the basis that most in the cohort were 
too young to have developed the major comorbidities studied. Weights of the 
estimates are relative to the inverse of square root of SE. Odds ratios are 
adjusted for sex, night-time light (as a proxy for socioeconomic status), urban 
or rural residence, alcohol, and smoking. OR=odds ratio.
1950s
590 cases
3370 controls
1960s
259 cases
2372 controls
1970s
122 cases
2529 controls
1
2
4
8
16
32
O
R 
(9
5%
 C
I)
Decade of birth
Diabetes
Hypertension
Heart disease
Renal failure cases (%) Renal failure controls (%)* Odds ratio (95% CI) Attributable fraction 
(%)†
2001–03 2010–13 2001–03 2010–13 2001–03 2010–13 2001–03 2010–13
Total‡ 1151 2943 7478 14 501 ·· ·· ·· ··
Residence
Urban 310 (27%) 930 (32%) 1300 (17%) 2977 (21%) 1·3 (1·1–1·4) 1·6 (1·4–1·8) ·· ··
Rural 841 (73%) 2013 (68%) 6178 (73%) 11 524 (79%) Ref Ref ·· ··
Comorbidities
Diabetes 257 (26%) 937 (34%) 85 (16%) 205 (23%) 9·2 (6·7–12·7) 15·1 (12·6–18·1) 56·8% 76·3%
Hypertension 274 (28%) 637 (23%) 228 (18%) 445 (16%) 4·0 (3·0–5·1) 2·0 (1·7–2·4) 35·4% 13·8%
Cardiovascular 
disease
111 (12%) 230 (8%) 105 (9%) 130 (6%) 2·7 (1·8–4·0) 2·2 (1·6–2·9) 13·3% 7·1%
Tuberculosis 30 (3%) 63 (2%) 48 (2%) 65 (2%) 3·0 (1·6–5·6) 1·3 (0·8–2·1) 4·4% 0·7%
Male§
Total 724 1892 45 660 61 328 ·· ·· ·· ··
Smoker 319 (45%) 679 (38%) 15 067 (34%) 10 735 (18%) 1·1 (0·9–1·3) 1·3 (1·2–1·5) 3·3% 5·6%
Alcohol drinker 211 (30%) 696 (38%) 7520 (17%) 6850 (12%) 1·9 (1·6–2·3) 4·0 (3·6–4·5) 13·4% 25·9%
The control group for comorbidities were MDS deaths from injuries (V00–Y99). The control group for lifestyle risk factors were living relatives of the cases, whose data were 
collected as part of the adult MDS survey. The comorbidity ORs adjust for age, gender, urban or rural residence, night-time light (as a proxy for socioeconomic status), each 
comorbidity, alcohol, and smoking. The selected risk factor ORs adjusted for age, urban or rural residence, and night-time light. Both OR calculations exclude cases with 
missing variables. *Percentages exclude missing records and are standardised to the age distribution of all cases in 2010–13. †Attributable fractions are of risk factors. ‡Total 
cases do not sum to the totals in Table 1 due to cases with missing variables for 2001–03. §Selected risk factors are presented for men. MDS=Million Death Study. ··=not 
applicable. Ref=reference group in the logistic regression model. OR=odds ratio.
Table 2: Comorbidity and risk of death from renal failure among Indian adults aged 15–69 years in 2001–03 and 2010–13: proportional mortality analysis
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diseases in rural and especially urban areas.5 Diabetes is a 
leading cause of chronic kidney disease in high-income 
countries,3 and our study ﬁ ndings suggest it is now also 
the leading risk factor associated with renal failure death 
in India. Health facility registry data in India show 
diabetic nephropathy to be the most common cause of 
chronic kidney disease9 and representative community 
surveys ﬁ nd a substantial prevalence of undiagnosed or 
poorly treated diabetes.32 In high-income countries, 
around 20–30% of diabetics develop kidney disease. 
Renal failure is typically considered a late complication of 
diabetes.6,33,34 Our data support other studies showing that 
most people with diabetes in India have poor glycaemic 
control.35,36 Hyperglycaemia, along with hypertension, 
dyslipidaemia, and genetic factors, all of which are 
reported among the Indian diabetic population, accelerate 
the onset of diabetic complications, including kidney 
damage.6,34 As a result, onset of diabetic kidney disease 
among Indian adults appears to occur at a much younger 
age (20–40 years) compared with high-income 
countries.34,37 The rising prevalence of diabetes, the 
increased risks among more contemporary birth cohorts, 
and the earlier onset of diabetic complications suggest 
the age-standardised rates of renal failure deaths in India 
will continue to increase throughout the coming decades, 
posing substantial challenges to health services and 
budgets.26,38 Moreover, other large populations, such as in 
Mexico39 and China,40 have high rates of untreated diabetes 
leading to excess mortality from renal and vascular 
disease, suggesting a global pattern among middle-
income countries.
We were unable to reliably diﬀ erentiate acute from 
chronic renal failure in this study using the verbal 
autopsy methodology, and therefore analysed all renal 
failure deaths together. Chronic kidney disease is not 
clinically detectable until very late in the disease process 
when it presents similarly to acute renal failure. The 
MDS deﬁ nitions of comorbidities relied on a history of 
a doctor previously diagnosing diabetes, hypertension, 
or cardiovascular disease. The true population prevalence 
of these conditions might be higher, including among 
the study cohorts, because these conditions remain 
underdiagnosed at the community level. We were also 
not able to capture in our study all comorbidities or 
environmental risks that might be causally associated 
with renal failure death, for example kidney stone 
disease. Chronic kidney disease also signiﬁ cantly 
increases the risk of premature cardiovascular death.3 
Therefore, the total number of deaths associated with 
kidney disease in India might be substantially higher 
than deaths attributed to renal failure alone.
Once established, patients with end-stage kidney 
disease require renal replacement therapy in the form of 
dialysis or kidney transplantation to prevent death. Data 
from a national survey25 of dialysis units in India report 
only 3·4 dialysis machines per million population in 
both the public and private sectors for those with 
end-stage renal failure in 2009. Further geospatial 
analysis of these units suggests low population coverage 
of dialysis facilities: on the basis of these data, almost 
60% of Indians live more than 50 km away from a health 
facility providing dialysis (appendix). 50 km or more are 
substantial distances given that patients in India mostly 
rely on haemodialysis and might require as many as ﬁ ve 
dialysis sessions per week. Kidney transplantation is 
the most eﬀ ective and cost-eﬀ ective treatment for kidney 
failure, particularly for diabetic nephropathy.41,42 Estimates 
of national kidney transplantation rates from the WHO 
Global Observatory on Organ Donation and 
Transplantation suggest that at only four transplantations 
per million population in India per year, transplantation 
is even less accessible than dialysis.28 By comparison, 
middle-income countries in South America, which have 
developed regulated transplant networks and national 
transplant registries, perform 25–35 kidney trans-
plantations per million population per year and most 
high-income countries perform more than 45 kidney 
transplantations per million population per year.28 The 
Indian Chronic Kidney Disease Registry reported that of 
the patients with end-stage kidney disease followed by a 
nephrologist, most (61%) were not on any form of renal 
replacement therapy: 32% were on haemodialysis, 5% on 
peritoneal dialysis, and 2% were being considered for, or 
were listed, for transplantation.9 A 2015 global review38 
suggests that as many as 83% of renal failure patients in 
Asia are not receiving the treatment they need.
Renal failure is a growing cause of premature adult 
mortality in India. Reductions in renal failure mortality 
require, most urgently, improved glycaemic control of 
patients with diabetes, paired with earlier diagnosis and 
prevention of diabetes and other key risk factors. Those 
patients with end-stage renal failure require substantially 
improved access to renal replacement therapy, especially 
transplantation.
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